Drugs / AMG 355
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06131398 | Mar 2024 → Jul 2026 overdue | cancer | Amgen | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 355 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06131398 ↗ |
| Route | Intravenous | “Short-term intravenous (IV) infusion” NCT06131398 ↗ |